Background Neuroendocrine tumours (NETs) are heterogeneous, with varying
presentations and treatment options. To our knowledge, there are no randomized and few …

Neuroendocrine tumors (NETs) have increased in incidence over time. A recent
Surveillance, Epidemiology, and End Results (SEER) database analysis showed that the …

Objectives: Neuroendocrine tumors (NETs) are uncommon malignancies with variable
natural history and often indolent biological behavior. Over the past decade, novel treatment …

Neuroendocrine tumors (NET) are usually slow-growing neoplasms carrying an overall
favorable prognosis. Surgery, from resection to transplantation, remains the only potential …

Background Neuroendocrine tumors (NETs) are a group of heterogeneous cancers arising
from a variety of anatomic sites. Their incidence has increased in recent years. This study …

Simple Summary This large single-center study of 615 patients with small intestinal
neuroendocrine tumors (siNET) showed that the risk of recurrence after intended radical …

Neuroendocrine tumours of the small intestine (SI-NETs) are rare and heterogeneous. There
is an unmet need for prognostication of disease course and to aid treatment strategies. A …

The rarity of neuroendocrine tumors (NET) has contributed to a paucity of large
epidemiologic studies of patients with this condition. We characterized presenting symptoms …

Objectives Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare but have
been increasing in incidence. Limited data on the long-term outcomes of patients with these …

Objective Neuroendocrine tumors (NETs) comprise 41.8% of small intestine malignancies.
The NET nomogram is a 15-item prognostic tool that includes relevant factors for guiding …